Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice
- PMID: 18844594
- DOI: 10.1586/14760584.7.8.1201
Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice
Abstract
The dermis and epidermis are alternative sites for prophylactic vaccination that have received renewed interest in recent years, not only because of the ease of access to the skin, but also its unique immunological properties. This review discusses the characteristics of the skin, current knowledge on skin immunity and clinical experience with cutaneous immunization against infectious diseases, with a special focus on intradermal immunization. The most widely accepted paradigm explaining the efficacy of cutaneous immunization is reviewed and recent research suggesting where this paradigm may need some refinement is highlighted. Clinical investigations that have concentrated on the intradermal route to vaccinate against influenza, rabies or hepatitis B support the current knowledge on skin immunity and, when combined with recent progress made in the development of user-friendly injection systems, have stimulated the ongoing clinical development of novel vaccines.
Similar articles
-
Transcutaneous and intradermal vaccination.Hum Vaccin. 2011 Aug;7(8):811-27. doi: 10.4161/hv.7.8.16274. Epub 2011 Aug 1. Hum Vaccin. 2011. PMID: 21817854 Review.
-
Particle-based vaccines for transcutaneous vaccination.Comp Immunol Microbiol Infect Dis. 2008 Mar;31(2-3):293-315. doi: 10.1016/j.cimid.2007.07.015. Epub 2007 Oct 30. Comp Immunol Microbiol Infect Dis. 2008. PMID: 17915323 Review.
-
Recent insights into cutaneous immunization: How to vaccinate via the skin.Vaccine. 2015 Sep 8;33(37):4663-74. doi: 10.1016/j.vaccine.2015.05.012. Epub 2015 May 23. Vaccine. 2015. PMID: 26006087 Review.
-
Needle-free epidermal powder immunization.Expert Rev Vaccines. 2002 Oct;1(3):265-76. doi: 10.1586/14760584.1.3.265. Expert Rev Vaccines. 2002. PMID: 12901567 Review.
-
Intradermal naked plasmid DNA immunization: mechanisms of action.Expert Rev Vaccines. 2011 Aug;10(8):1169-82. doi: 10.1586/erv.11.66. Expert Rev Vaccines. 2011. PMID: 21854310 Review.
Cited by
-
Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen.PLoS One. 2014 Dec 23;9(12):e113978. doi: 10.1371/journal.pone.0113978. eCollection 2014. PLoS One. 2014. PMID: 25536061 Free PMC article.
-
A pilot clinical trial of a near-infrared laser vaccine adjuvant: safety, tolerability, and cutaneous immune cell trafficking.FASEB J. 2019 Feb;33(2):3074-3081. doi: 10.1096/fj.201801095R. Epub 2018 Sep 7. FASEB J. 2019. PMID: 30192655 Free PMC article. Clinical Trial.
-
Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats.Pharm Res. 2014 Jul;31(7):1846-54. doi: 10.1007/s11095-013-1288-9. Epub 2014 Jan 28. Pharm Res. 2014. PMID: 24469907
-
Intradermal active full-length DNA Aβ42 immunization via electroporation leads to high anti-Aβ antibody levels in wild-type mice.J Neuroimmunol. 2018 Sep 15;322:15-25. doi: 10.1016/j.jneuroim.2018.05.017. Epub 2018 Jun 11. J Neuroimmunol. 2018. PMID: 29958693 Free PMC article.
-
Induction of mucosal immunity through systemic immunization: Phantom or reality?Hum Vaccin Immunother. 2016 Apr 2;12(4):1070-9. doi: 10.1080/21645515.2015.1114195. Epub 2016 Jan 11. Hum Vaccin Immunother. 2016. PMID: 26752023 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical